Minimization and management of wastes from biomedical research

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 6, 2000, Pages 953-977

  Rau, E H ^a   Alaimo, R J ^a   Ashbrook, P C ^a   Austin, S M ^a   Borenstein, N ^a   Evans, M R ^a   French, H M ^a   Gilpin, R W ^a   Hughes Jr , J ^a   Hummel, S J ^a   Jacobsohn, A P ^a   Lee, C Y ^a   Merkle, S ^a   Radzinski, T ^a   Sloane, R ^a   Wagner, K D ^a   Weaner, L E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biohazardous waste; Biomedical research facilities; Chemical waste; Drug waste; Hazardous waste; Laboratories; Medical waste; Minimization; Mixed waste; Multihazardous waste; Pollution prevention; Radioactive waste; Recycling; Solid waste; Training; Waste disposal

Indexed keywords

CHEMICAL AGENT; RADIOACTIVE MATERIAL; RADIOISOTOPE;

ARTICLE; BIOACCUMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DANGEROUS GOODS; ENVIRONMENTAL HEALTH; ENVIRONMENTAL PROTECTION; GOOD LABORATORY PRACTICE; HAZARDOUS WASTE; HEALTH CARE FACILITY; LABORATORY TEST; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; NATIONAL HEALTH SERVICE; POLLUTION CONTROL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; UNITED STATES; WASTE MANAGEMENT;

EID: 0034496287     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s6953     Document Type: Article

References (219)

1. Medical facilities to focus on cleaner environment
2. The environment and biomedical research
3. SHEA Position Paper: Medical waste
4. Partnerships under pressure: Managing low-level radioactive waste
5. EPA offices push colleges to comply with environmental regulations
6. Executive Order 13148 of April 21, 2000. Greening of the Government Through Environmental Leadership
7. Pollution prevention and waste minimization in laboratories
8. Hazardous materials: Revision to standards for infectious substances and genetically modified microorganisms
9. Defining and characterizing the waste stream of healthcare facilities
10. The public health implications of medical waste. A report to congress by the US agency for toxic substances and disease registry
11. Infectious waste management and laboratory design criteria
12. Management of infectious waste by US hospitals
13. The microbiological hazards of municipal and clinical wastes
14. Medical waste incineration
15. Effective cost-reduction strategies in the management of regulated medical waste
16. Reprocessing disposables: One strategy to balance cost reduction and quality patient care
17. Reprocessing unused surgical supplies for use in developing countries
18. Appendix C. Reuse of healthcare supplies: Organizations, programs and information
19. Dissolving medical waste
20. Nonincineration treatment technologies
21. Appendix E. Technical assistance manual: State regulatory oversight of medical waste treatment technologies
22. New studies on the heat resistance of hamster-adapted scrapie agent threshold survival after ashing at 600°C suggests an inorganic template of replication
23. Transmissible degenerative encephalopathies
24. Inactivation of prions by physical and chemical means
25. Inactivation of transmissible degenerative encephalopathy agents: A review
26. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in healthcare setting
27. Deposit-refund systems: A solution to medical waste management
28. CE Update - Pollution Prevention. I: The role of chemical substitution in pollution prevention programs
29. CE Update - Pollution Prevention. II: The laboratory's role in reducing hazardous waste
30. Appendix F. Hazardous waste
31. Technical Environmental Impacts of Various Approaches for Regulating Small Volume Hazardous Waste Generators
32. BGSU's orphan chemical recycling program
33. Chemical waste disposal and recycling in an academic medical center
34. Will mercury manometers soon be obsolete?
35. Should we ban the mercury thermometer? Discussion paper
36. The health risks of removing mercury manometers from the hospital and clinic
37. Standard reference materials: Description and use of a precision thermometer for the clinical laboratory
38. The use of infrared ear thermometers in pediatric and family practice offices
39. Laboratory and hospital testing of new infrared tympanic thermometers
40. Guidance article on infrared ear thermometers
41. Accuracy of infrared ear thermometry and other temperature methods in adults
42. Accuracy and reliability of temperature measurement in the emergency department by instrument and site in children
43. 354 new weapons are in development for the war on cancer. New medicines in development for cancer. 1999 Survey
44. The disposal of pharmaceutical waste
45. Notice of proposed rulemaking
46. Disposal of antineoplastic wastes at the National Institutes of Health
47. What happens to expired medications? A survey of community medication disposal
48. Occurrence, fate and effects of pharmaceutical substances in the environment: A review
49. Pharmaceuticals and personal care products in the environment: Agents of subtle change
50. Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria
51. Studies indicate drugs in water may come from effluent discharges
52. Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicylic acid in sewage water effluent
53. Detection of drugs and drug metabolites in ground water samples of a drinking water treatment plant
54. Determination of pharmaceutics in sewage plants and river water
55. Occurrence of the pharmaceutical drug clofibric acid and the herbicide Mecoprop in various Swiss lakes and in the North Sea
56. Biological degradation of cyclophosphamide and its occurrence in sewage water
57. Occurrence of clofibric acid in the aquatic system-Is the use in human medical care the source of the contamination of surface, ground and drinking water?
58. Transferable drug resistance associated with coliforms isolated from hospital and domestic sewage
59. Antibiotic resistance patterns of fecal coliforms isolated from domestic sewage before and after treatment in an aerobic lagoon
60. Influence of sewage treatment and urbanization on selection of multiple resistance in fecal coliforms populations
61. Occurrence of multiple antibiotic-resistant bacteria in domestic sewage and oxidation lagoons
62. Incidence of antibiotic resistance and sex pheromone response among enterocci isolated from clinical human samples and from municipal wastewater
63. Association of multiple-antibiotic-resistance profiles with point and nonpoint sources of Escherichia coli in Apalachiocola Bay
64. Antibiotic resistance in Acinetobacter spp. isolated from sewers receiving waste effluent from a hospital and a pharmaceutical plant
65. The fate of pharmaceutical chemists in the aquatic environment
66. The action of antibiotics on the anaerobic digestion process
67. Defining the future of health care delivery
68. Identification of fluoroquinone antibiotics as the main source of umuC genotoxicity in native hospital wastewater
69. Cytotoxic drugs and the aquatic environment: Estimation of bleomycin in river and water samples
70. Identification of estrogenic chemicals in STW effluent. 1: Chemical fractionation and in vitro biological screening
71. Widespread sexual disruption in wild fish
72. Identification of estrogenic chemicals in STW effluent. 2: In vivo responses in trout and roach
73. Gilding the Lilly
74. Project cuts waste by tailoring ordering, production, distribution
75. Antineoplastic and other hazardous drug waste management
76. Low-Level Radioactive Waste Management in Medical and Biomedical Research Institutions
77. 1995 State-by-State Assessment of Low-Level Radioactive Wastes Received at Commercial Disposal Sites
78. 1996 State-by-State Assessment of Low-Level Radioactive Wastes Received at Commercial Disposal Sites
79. 1997 State-by-State Assessment of Low-Level Radioactive Wastes Received at Commercial Disposal Sites
80. An Evaluation of Exposure Pathways to Man from Disposal of Radioactive Materials Into Sanitary Sewer Systems
81. 1994 Action Needed to Control Radioactive Contamination at Sewage Treatment Plants
82. A review of some available radioactive and non-radioactive substitutes for use in biomedical research
83. Commercial Radioactive Waste Minimization Program Development Guidance
84. Low-level radioactive waste management
85. Radiation safety in a large academic program
86. Minimizing and managing low-level radioactive waste
87. Monitoring of 35S in ash of incinerated waste
88. Low-level waste management in an academic medical center
89. Freeze-drying as a potential means for waste handling of animal carcasses containing radioactive material
90. Pretreatment of animal wastes containing radioisotopes with dry-distillation
91. States are not developing disposal facilities
92. Radioactive waste volume reduction in a university/hospital setting
93. Radioactive waste management at a large university and medical research complex
94. Recommendations for radioactive waste reduction in biomedical/academic institutions
95. Low-Level Radioactive Waste Management in Medical and Biomedical Research Institutions
96. Prudent Practices in the Laboratory: Handling and Disposal of Chemicals
97. Guidelines for Mixed Waste Minimization
98. Mixed Waste Minimization Strategies: Guidance for Investigators
99. Extension of the policy on enforcement of RCRA section 3004(j) storage prohibition at facilities generating mixed radio-active/hazardous waste
100. Trends in management and minimization of biomedical mixed wastes at the National Institutes of Health
101. Storage, treatment, transportation, and disposal of mixed waste, proposed rule
102. A prototype high-temperature catalytic oxidation process for mixed waste in a pharmaceutical research laboratory
103. Characterization of Municipal Solid Waste in the United States: 1995 Update Executive Summary. EPA 530-S-96-001
104. Minimization of medical waste through total integrated waste management
105. Hazardous waste management
106. Laboratory Waste Management
107. NIH Waste Disposal Guide
108. Mixed waste: A major issue in biomedical research (a video film)
109. Radiation safety refresher training, waste minimization review and update (a video film)
110. Transportation of regulated waste compliance assistance document
111. Association of operating room nurses (AORN) recommended practices for environmental responsibility in the practice setting
112. JCAHO Standard for Hazardous Materials and Waste
113. Non-governmental agencies and their standards and guidance
114. What Makes Labs Unique?
115. Fear and loathing on a campus dispelled after a RCRA inspection
116. Prudent practices for disposal of chemicals from laboratories
117. Regional treatment strategies for unresectable primary or metastatic cancer confined to the liver
118. Isolated hepatic perfusion: A potentially effective treatment for patients with metastatic or primary cancers confined to the liver
119. Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms
120. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
121. Partial responses encourage doctors to continue isolated hepatic perfusion for patient with colorectal cancer mets to liver
122. A survey of laboratory waste management and minimization practices
123. The emergence of environmental concerns for healthcare facilities
124. Report of the NIH committee on alternatives to radioactivity (NCAR) to the Deputy Director for Intramural Research
125. Biodegradable liquid scintillation counting cocktails
126. Liquid scintillation sample analysis in microcentrifuge tubes
127. Solid scintillation counting: A new technique for measuring radiolabeled compounds
128. Laboratory on a chip: A new experimentation format
129. Revolution of the drug discovery process using laboratory-on-a-chip technology
130. Development of a pollution prevention and energy efficiency clearinghouse for biomedical research facilities